Serum remnant-like lipoprotein concentration regulator

Details Serum remnant-like lipoprotein concentration regulator Serum remnant-like lipoprotein concentration regulator

2008-05-27

2008-05-27

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C424S776000, C514S171000, C514S458000, C514S547000

Reexamination Certificate

active

07378107

ABSTRACT:
The present invention discloses serum remnant-like lipoprotein concentration regulators containing triglyceride of medium-chain fatty acids, wherein 90% or more by weight of the fatty acids as components of the medium-chain triglyceride are saturated fatty acids having 8 and 10 carbon atoms; weight ratio between the saturated fatty acids having 8 carbon atoms and those having 10 carbon atoms is 60/40 to 85/15; and the proportion of the saturated fatty acids having 8 carbon atoms in all the fatty acids bonding to the second position of the triglyceride is 60 to 85 % by weight. The present invention also discloses foods for controlling the concentration of serum remnant-like lipoproteins and pharmaceutical compositions for controlling the concentration of serum remnant-like lipoproteins, which contain the serum remnant-like lipoprotein concentration regulator. The foods for controlling the concentration of serum remnant-like lipoproteins can be easily used without concerning about side effects and restrictive diet.

REFERENCES:
patent: 3450819 (1969-06-01), Barsky et al.
patent: 2004/0071751 (2004-04-01), Maki et al.
patent: 2004/0142018 (2004-07-01), Takeuchi et al.
patent: 0 537 113 (1993-04-01), None
patent: 57-047446 (1982-03-01), None
patent: 2-207764 (1990-08-01), None
patent: 6-007113 (1994-01-01), None
Nutrition Facts and Analysis for Oil (primary safflower oil) Jun. 19, 2006 p. 4 of 4.
Derwent-Acc-No. 1982-33891E abstacting Kajimoto et al. JP57047446A 1982 2 pages.
The Japanese Society of Nutrition and Food Science, Dai 56 Kai The Japanese Society of Nutrition and Food Science Taikai, Koen Yoshishu, Jun. 20, 2002, p. 319 (cited in International Search Report).
Robert W. Mahley, “Atherogenic Lipoprotein and Coronary Artery Disease: Concepts Derived from Recent Advances in Cellular and Molecular Biology”, Circulation, An Official Journal of the American Heart Association, Inc., Nov. 1985, pp. 943-948, vol. 72, No. 5 (cited in the specification).
Shotaro Kosaka, et al., “Evidence of Macrophage Foam Cell Formation by Very Low-Density Lipoprotein Receptor”, Circulation, Feb. 27, 2001, pp. 1142-1147 (cited in the specification).
Donald B. Zilversmit, “Atherogenesis: A Postprandial Phenomenon”, Circulation, George Lyman Duff Memorial Lecture, Sep. 1979, pp. 473-485, vol. 60, No. 3 (cited in the specification).
Fredrik Karpe et al., “Postprandial Lipoproteins and Progression of Coronary Atherosclerosis”, Atherosclerosis, 1994, pp. 83-97, vol. 106, Elsevier Science Ireland Ltd. (cited in the specification).
Katsuyuki Nakajima et al., “Cholesterol in Remnant-Like Lipoproteins in Human Serum Using Monoclonal Anti APO B-100 and Anti APO A-1 Immunoaffinity Mixed Gels”, Clinica Chimica Acta, 1993, pp. 53-71, vol. 223, Elsevier Science Publishers B.V. (cited in the specification).
Carlo Calabrese et al., “A Cross-Over Study of the Effect of Single Oral Feeding of Medium Chain Triglyceride Oil vs. Canola Oil on Post-Ingestion Plasma Triglyceride Levels in Healthy Men”, Alternative Medicine Review, 1999, pp. 23-28, vol. 4, No. 1 (cited in the specification).
Form PCT/ISA/210 (International Search Report dated Jun. 15, 2004).
Form PCT/ISA/237 (Written Opinion of the International Searching Authority dated May 31, 2004).

Affiliated with

Also associated with

Rating

Serum remnant-like lipoprotein concentration regulator does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serum remnant-like lipoprotein concentration regulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum remnant-like lipoprotein concentration regulator will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2768475